Binding activities of infliximab and etanercept to transmembrane tumor necrosis factor-α
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference6 articles.
1. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease;Van den Brande;Gastroenterology,2003
2. Membrane tumor necrosis factor-α (TNF-α) expressed on HTLV-infected T cells mediates a costimulatory signal for B cell activation-characterization of membrane TNF-α;Higuchi;Clin Immunol Immunopathol,1997
3. A casein kinase I motif present in the cytoplasmic domain of members of the tumoir necrosis factor ligand family is implicated in ‘reverse signalling’;Watts;EMBO J,1999
4. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages;Eissner;J Immunol,2000
5. Outside-to-inside signal through the membrane TNF-α induces E-selection (CD62E) expression on activated human CD4+ T cells;Harashima;J Immunol,2001
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn’s disease patients;European Journal of Gastroenterology & Hepatology;2023-07-31
2. Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis;International Journal of Molecular Sciences;2022-11-11
3. Etanercept and Infliximab, Two Tumor Necrosis Factor-α (TNF-α) Inhibitors With Different Action Profiles: An In vitro and In Vivo Study in the Context of Reviewed Therapeutic Applications;Biointerface Research in Applied Chemistry;2022-09-11
4. An Overview of Tumor Necrosis Factor-α on Pathophysiological Mechanisms, Relevant Therapeutic Status in Breast Cancer;Highlights in Science, Engineering and Technology;2022-08-17
5. TNFR2 Signaling Enhances Suppressive Abilities of Human Circulating T Follicular Regulatory Cells;The Journal of Immunology;2022-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3